Financhill
Back

AnaptysBio Quote, Financials, Valuation and Earnings

AnaptysBio Price Quote

$14.55
+0.05 (+-3%)
(Updated: December 21, 2024 at 5:14 AM ET)

AnaptysBio Key Stats

Sell
16
AnaptysBio (ANAB) is a Sell

Day range:
$14.20 - $15.29
52-week range:
$14.20 - $41.31
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.95
P/B ratio:
5.23%

Volume:
1.6M
Avg. volume:
686.3K
1-year change:
-25.68%
Market cap:
$441.2M
Revenue:
$17.2M
EPS:
$-6.08

How Much Does AnaptysBio Make?

Data Unavailable

Is AnaptysBio Growing As A Company?

Data Unavailable

AnaptysBio Stock Price Performance

  • Did AnaptysBio Stock Go Up Last Month?
    AnaptysBio share price went down by -28.61% last month
  • Did ANAB's Share Price Rise Over The Last Year?
    ANAB share price fell by -25.68% over the past 1 year

What Is AnaptysBio 52-Week High & Low?

  • What Is AnaptysBio’s 52-Week High Share Price?
    AnaptysBio has traded as high as $41.31 over the past 52 weeks
  • What Is AnaptysBio’s 52-Week Low Share Price?
    AnaptysBio has traded as low as $14.20 over the past 52 weeks

AnaptysBio Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy AnaptysBio?

Data Unavailable

Is AnaptysBio Cash Flow Positive?

Data Unavailable

AnaptysBio Return On Invested Capital

Data Unavailable

AnaptysBio Earnings Date & Stock Price

  • What Is AnaptysBio's Stock Price Today?
    A single share of ANAB can be purchased today for 14.50
  • What Is AnaptysBio’s Stock Symbol?
    AnaptysBio trades on the nasdaq under the ticker symbol: ANAB
  • When Is AnaptysBio’s Next Earnings Date?
    The next quarterly earnings date for AnaptysBio is scheduled on March 11, 2025
  • When Is ANAB's next ex-dividend date?
    AnaptysBio's next ex-dividend date is December 22, 2024
  • How To Buy AnaptysBio Stock?
    You can buy AnaptysBio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

AnaptysBio Competitors

  • Who Are AnaptysBio's Competitors?
    Below is a list of companies who compete with AnaptysBio or are related in some way:
    • Candel Therapeutics Inc (CADL)
    • Eli Lilly and Co (LLY)
    • NovaBay Pharmaceuticals Inc (NBY)
    • Palatin Technologies Inc (PTN)
    • SIGA Technologies Inc (SIGA)

AnaptysBio Dividend Yield

Data Unavailable

AnaptysBio Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 29.29%
Revenue: 804.67% 267.6%

Analyst Recommendations

Buy Recommendations: 6
Hold Recommendations: 3
Sell Recommendations: 0
Price Target: 35.70
Upside from Last Price: 146.21%

Major Shareholders

Data Unavailable